A recent study revealed that by inhibiting lysine demethylase 2A (KDM2A)-mediated demethylation of H3K26m2, ZHX2 downregulates the expression of stemness genes, including EPCAM, in hepatocellular carcinoma stem cells [125]. This evidence concerns the gene KDM2A and hepatocellular carcinoma.